Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • metheuse
    Member
    • Jan 2013
    • 84

    #1

    Questions in calling SNPs from RNA-seq reads

    I'm trying to call SNPs from RNA-seq data.
    The workflow I'm trying to follow is: tophat2 --> remove duplicates --> local realignment and base quality recalibration by GATK --> call SNPs by samtools mpileup or GATK

    These are some specific questions:

    1. Should I filter the alignment from tophat2 to get only the uniquely mapped reads (reads that could only be mapped to single location on the genome)? If yes, how should I filter them?
    I know there is a --multihits (-g) parameter in tophat that can be set to 1 to report only one hit per mapped read. But this is not the strict definition of "unique mapping". I saw people saying that in the alignment sam file, if MAPQ=50, that means this read can only be mapped to a single position. Could I, for example, run tophat2 with g=20 (default), and then select only the aligned reads with MAPQ=50?

    2. GATK cannot accept N in cigar. How should I deal with the aligned reads with N in the cigar? GATK has two options: the first is to remove these reads; the second is to allow N in cigar. The former strategy may lose a lot of information, while the latter is at risk (I don't know what the risk is exactly).

    3. To use samtools mpileup, how should I set the -C (parameter for adjusting mapQ) parameter? I know it recommends 50 for bwa aligned reads, but what it is for tophat2 alignment?

    4. If you have experience in this kind of data analysis, can you see any other potential problems in the pipeline or the parameters of each program? Do you have any recommendation?

    By the way, I know there are a lot of caveats of using RNA-seq data to call SNPs. The major purpose of this project is to measure expression, but calling SNPs is to try to get more use of the data (or the money).

    Thanks a lot for any suggestions or advice!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
41 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...